A human study to evaluate the effectiveness and safety of propolis extract on skin condition improvement in children with atopic dermatitis: a randomized, double-blind, parallel, placebo-controlled study

Seoul National University of Science and Technology0 个研究点目标入组 84 人开始时间: 待定最近更新: 2024年4月2日

适应症

试验速览

暂无简介。

•1) Subject who voluntarily agrees to participate and subjects and their parents (or legal representatives) sign in informed consent form
•2) The ages of between 4 and 65 with intermittent or persistent symptoms of atopic dermatitis for more than 6 months

•1) Subjects who have systemic diseases such as skin diseases except for atopic dermatitis, immunodeficiency, autoimmune diseases, cancer, etc.
•2) Use of systemic antibiotics, corticosteroids, or immunosuppressants related to atopic dermatitis within 1 month of the first visit
•3) Use of medication related atopic dermatitis such as antihistamines, herbal medicines, or health functional foods within 1 month of the first visit
•4) Presence of received phototherapy within 1 month of the first visit
•5) History of hypersensitivity including ingredients (propolis, honey) or pollen in the placebo/test material, or severe food allergic reactions
•6) Subjects who plan to participate in another clinical trial during current participation
•7) Participation in another clinical trial within 1 month of the first visit
•8) Subjects who, in the investigator's judgment, have a condition that would not allow to participate in the study

发起方